Jul 2, 2026 08:05AM
May 19, 2026 08:05AM
Apr 9, 2026 08:05AM
Mar 23, 2026 08:05AM
Mar 23, 2026 08:05AM
Mar 10, 2026 08:05AM
Mar 10, 2026 08:05AM NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026
Jan 22, 2026 08:05AM
Jan 22, 2026 08:05AM
Dec 3, 2025 08:05AM
Oct 9, 2025 08:05AM
Oct 6, 2025 08:05AM
Sep 18, 2025 08:05AM
Sep 18, 2025 08:05AM NKGen Biotech to Present on the Use of Troculeucel for Neurodegenerative Diseases at the 3rd China Great Bay Cell and Gene Therapy Forum
Sep 9, 2025 08:05AM
Jul 16, 2025 05:45PM
Dec 2, 2024 04:08PM
Dec 2, 2024 04:05PM
Nov 26, 2024 04:19PM
Nov 26, 2024 04:15PM
Nov 14, 2023 04:48PM NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Oct 2, 2023 08:00AM

1,167,056 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All